U.S. markets closed

AVITA Medical, Inc. (51KA.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
12.300.00 (0.00%)
At close: 09:18AM CEST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close12.30
Bid12.20 x N/A
Ask12.30 x N/A
Day's Range12.30 - 12.30
52 Week Range4.30 - 13.50
Avg. Volume0
Market Cap319.303M
Beta (5Y Monthly)0.97
PE Ratio (TTM)N/A
EPS (TTM)-0.99
Earnings DateFeb 23, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est40.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for 51KA.F

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Zacks

      Pacira's (PCRX) sNDA for Exparel Accepted for FDA Review

      The FDA accepts Pacira's (PCRX) sNDA filing, which seeks to expand the label of its pain drug Exparel to include both sciatic and femoral nerve blocks. A final decision is expected by November 2023.

    • GlobeNewswire

      AVITA Medical Appoints New Non-Executive Member to the Board of Directors

      VALENCIA, Calif. and MELBOURNE, Australia, March 23, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today the appointment of Robert McNamara to its Board of Directors, effective April 1, 2023. Mr. McNamara is an accomplished senior executive with over 25 years of leadership experience in public and privat

    • Zacks

      What Makes Avita Medical Inc. (RCEL) a Good Fit for 'Trend Investing'

      Avita Medical Inc. (RCEL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.